Lisinopril Dispensing Quantity and Dosing
For hypertension, dispense a 30-day supply of 10-20 mg tablets (30 tablets for once-daily dosing), with the standard starting dose being 10 mg once daily and usual maintenance range of 20-40 mg daily. 1
Standard Dispensing Quantities by Indication
Hypertension
- Initial prescription: Dispense 30 tablets of 10 mg strength for once-daily dosing 1
- Maintenance prescription: Dispense 30 tablets of 20 mg strength (most common maintenance dose) or 40 mg strength depending on titration 1
- The FDA-approved dosing range is 20-40 mg daily as a single dose, though doses up to 80 mg have been used 1
Heart Failure
- Initial prescription: Dispense 30 tablets of 5 mg strength (or 2.5 mg if patient has hyponatremia with serum sodium <130 mEq/L) 1
- Target maintenance prescription: Dispense 30 tablets of 30-35 mg strength for optimal outcomes 2, 3
- The European Society of Cardiology recommends targeting 30-35 mg once daily, as high-dose lisinopril (32.5-35 mg daily) reduces death or hospitalization by 12% and heart failure hospitalizations by 24% compared to low doses 4, 2, 5
- Maximum FDA-approved dose is 40 mg daily 1
Post-Myocardial Infarction
- Initial prescription: Dispense 30 tablets of 5 mg strength (or 2.5 mg if systolic BP ≤120 mmHg) 1
- Maintenance prescription: Dispense 30 tablets of 10 mg strength for once-daily dosing 1
- Therapy should continue for at least 6 weeks 1
Dose Adjustments for Renal Impairment
Moderate Renal Impairment (CrCl 10-30 mL/min)
- Initial prescription: Dispense 30 tablets of 5 mg strength for hypertension, or 2.5 mg for heart failure 1
- Reduce initial dose to half the usual recommended dose 1
- The European Heart Journal recommends dose adaptation when CrCl <30 mL/min, with initial dose of 1.25 mg daily and maximum of 5 mg/day 4
Severe Renal Impairment (CrCl <10 mL/min or Hemodialysis)
- Initial prescription: Dispense 30 tablets of 2.5 mg strength 1
- Start at 2.5 mg once daily and titrate as tolerated 1, 6, 7
Titration Schedule and Monitoring
Dose Escalation Protocol
- Increase doses at minimum 2-week intervals to allow full assessment of blood pressure response 4, 2, 3
- Double the dose at each titration step until target or maximum tolerated dose is reached 4
- For heart failure patients, aim for at least 50% of target dose (minimum 10 mg daily) for optimal clinical benefit 2
Monitoring Requirements
- Check blood pressure, serum creatinine, and potassium within 5-7 days after initiation or any dose increase 2, 3
- Repeat monitoring at 3 months, then every 6 months during maintenance therapy 2, 3
- An increase in creatinine up to 50% above baseline is acceptable during titration 2, 3
Critical Prescribing Considerations
When to Use Lower Starting Doses
- Volume depletion or concurrent diuretic use: Start with 5 mg daily for hypertension 1
- Hyponatremia (sodium <130 mEq/L): Start with 2.5 mg daily for heart failure 1
- Low systolic BP (≤120 mmHg) post-MI: Start with 2.5 mg daily 1
- Elderly patients or those with renal impairment: Consider starting at lower doses 8
Important Pitfalls to Avoid
- Asymptomatic hypotension does not require dose reduction—only symptomatic hypotension warrants intervention 4, 3
- Avoid NSAIDs and COX-2 inhibitors as they reduce ACE inhibitor efficacy and worsen renal function 3
- Avoid potassium-sparing diuretics during initiation due to hyperkalemia risk 3
- Some ACE inhibitor is better than no ACE inhibitor—use the highest tolerated dose even if target cannot be reached 4, 2
Pediatric Dosing (Age ≥6 years with GFR >30 mL/min/1.73m²)
- Start at 0.07 mg/kg once daily (maximum 5 mg) 1
- Titrate to maximum of 0.61 mg/kg once daily (not exceeding 40 mg) 1
- Calculate total monthly tablets needed based on weight-based dosing
Practical Dispensing Recommendations
For a typical new hypertension patient: Dispense #30 tablets of 10 mg strength with instructions for once-daily dosing, with refills allowing titration to 20-40 mg daily 1
For a heart failure patient: Dispense #30 tablets of 5 mg strength initially, with plan to titrate toward 30-35 mg daily over subsequent months for optimal mortality benefit 2, 5